Translumina Therapeutics Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2025.
2025 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Translumina Therapeutics Private Limited

Translumina Therapeutics Private Limited, a active private limited company, was established on 25 January 2025 in New Delhi, Delhi, India. it holds CIN: U32509DL2025PTC441712. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Indranil Mukherjee (Nominee Director), Punita Sharma (Nominee Director), Vishal Omprakash Goenka (Nominee Director). Past directors included Vishal Sharma, Amit Manocha, Kewal Krishan. It holds ₹261.55 Cr open charges and ₹9.65 Cr settled loans. It is based at Plot No. 1 Ground Floor, Lsc M.O.R Land, New Delhi, Delhi, 110060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U32509DL2025PTC441712

  • Registration Number

    441712

  • Incorporation Date

    25 January 2025

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 30 Days
  • Open Charges ₹ 261.55 Cr
  • Satisfied Charges ₹ 9.65 Cr
Company report

Translumina Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Translumina Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Translumina Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Indranil Mukherjee Nominee Director 25 Jan 2025 Current
Punita Sharma Nominee Director 25 Jan 2025 Current
Vishal Omprakash Goenka Nominee Director 25 Jan 2025 Current
Rajani Kesari Additional Director 08 Oct 2025 Current
Arjun Oberoi Additional Director 17 Sep 2025 Current
Avnish Mehra Additional Director 17 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 25 Mar 2025 Past
Pramod Abcsdd Additional Director 21 Jul 2025 Past
Pramod Abcsdd Cfo - Past
Pramod Abcsdd Non- Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Translumina Therapeutics.
Translumina Therapeutics revenue growth over time
Translumina Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Translumina Therapeutics?

Unlock access to Translumina Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,615,500,570.00

Satisfied Charges

₹96,502,990.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 200.55 Cr
  • Citi Bank N.A : 50.00 Cr
  • Icici Bank Limited : 11.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Jun 2025 Hdfc Bank Limited ₹60.00 Cr Open
12 Jun 2023 Citi Bank N.A ₹50.00 Cr Open
18 Nov 2022 Hdfc Bank Limited ₹2.30 M Open
30 Aug 2022 Icici Bank Limited ₹11.00 Cr Open
20 Apr 2022 Hdfc Bank Limited ₹1.61 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Translumina Therapeutics?

Unlock and access historical data on people associated with Translumina Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Translumina Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translumina Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Translumina Therapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Rajani Kesari was appointed as a Additional Director was appointed as a Additional Director on 08 Oct 2025 & has been associated with this company since 4 months 19 days . was completed.

  • Director Appointment

    The activity Arjun Oberoi was appointed as a Additional Director was appointed as a Additional Director on 17 Sep 2025 & has been associated with this company since 5 months 9 days . was completed.

  • Director Appointment

    Avnish Mehra was appointed as a Additional Director was appointed as a Additional Director on 17 Sep 2025 & has been associated with this company since 5 months 9 days . was recorded as a recent event.

  • Director Appointment

    The activity Gurmit Singh Chugh was appointed as a Additional Director was appointed as a Additional Director on 17 Sep 2025 & has been associated with this company since 5 months 9 days . was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 60.00 Cr with Charge ID 101140772 was registered on 27 Jun 2025. was completed.

  • Director Appointment

    The activity Kewal Krishan was appointed as a Cfo was appointed as a Cfo on 24 Feb 2025 & has been associated with this company since 1 year . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Translumina Therapeutics Private Limited?

The CIN of Translumina Therapeutics Private Limited is U32509DL2025PTC441712.

Where is Translumina Therapeutics Private Limited headquartered?

Translumina Therapeutics Private Limited is headquartered at Plot No. 1 Ground Floor, Lsc M.O.R Land, New Delhi, Delhi, 110060.

When was Translumina Therapeutics Private Limited incorporated?

Translumina Therapeutics Private Limited was incorporated on 25 January 2025.

Who are the current directors of Translumina Therapeutics Private Limited?

The current directors of Translumina Therapeutics Private Limited are

Is Translumina Therapeutics Private Limited a listed company?

Translumina Therapeutics Private Limited is unlisted.

What is the capital structure of Translumina Therapeutics Private Limited?

The authorized capital of Translumina Therapeutics Private Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available